Factors associated with rituximab-mediated B cell depletion in ABO-incompatible adult living donor liver transplantation

Background : Pretransplant therapies such as rituximab and plasmapheresis have led to an increase in ABO-incompatible (ABOi) living donor liver transplantation (LDLT), thus helping to overcome organ shortages. This study evaluated the changes in anti-A/B titers and CD19 levels over time in patients...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Suk Kyun Hong, Kwang-Woong Lee, Jae-Yoon Kim, Jaewon Lee, Jiyoung Kim, Hyun Hwa Choi, Su young Hong, Jeong-Moo Lee, YoungRok Choi, Nam-Joon Yi, Kyung-Suk Suh
Format:	Artigo
Sprog:	Inglês
Udgivet:	Korean Society for Transplantation 2023-09-01
Serier:	Korean Journal of Transplantation
Fag:	liver transplantation; abo blood-group system; rituximab; polymorphism
Online adgang:	http://www.ekjt.org/journal/view.html?doi=10.4285/kjt.23.0031
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!